Skip to content
WeighLab
Grade C

Vyvron Review: Price, Pros & Cons

By The WeighLab Bench, Tools & Data Desk

Vyvron charges $199 every four weeks for compounded GLP-1 care at its founding-member rate, which adds up to 13 charges a year and rises to $249 once its founding spots fill.

Read the full review

This page is the Vyvron scorecard, with the most recent prices we've checked. Our full review goes deeper on how its plans, billing and policies work: Vyvron Review: $199 a Month Is Really 13 Charges a Year.

Visit Vyvron Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. See our disclosure.
Semaglutide
$199Every 4 weeks (founding-member price; $249 after the founding spots fill, compounded)
Tirzepatide
Not disclosed
Coverage
49 states (not Mississippi)
Brand-name
Compounded only

Semaglutide · modeled / year

$2,587

13 charges a year: billed every four weeks

The Index scorecard

Vyvron scored on our six Cost-Efficiency Index factors. See the methodology.

Normalized Cost/Month52/100
Price Transparency84/100
Nationwide Access78/100
Formulation Options53/100
Clinical Oversight73/100
Contract Flexibility73/100

Where the value is

  • One price covers the provider evaluation, the medication if prescribed, ongoing check-ins and shipping, with no membership fee
  • No long-term contract and no cancellation fee; you cancel by email or in the patient portal
  • Full refund if a provider doesn't approve you
  • Names its partner pharmacy, RedRock Pharmacy, and its clinical partner in its terms

The tradeoffs

  • Billing is every four weeks, not monthly, so a year at $199 is 13 charges and $2,587
  • The pages don't say whether tirzepatide costs the same as semaglutide; the provider chooses which one you get
  • The homepage says there's no "from $" asterisk, while the programs page lists the same plan as "starting at $199/mo"
  • The homepage and programs page disagree on other prices: microdosing is $149 on one and $179 on the other, longevity $189 and $145
  • You're charged up front before a provider reviews you, and there's no refund for the cycle in which you cancel
  • Cancellations need 72 hours' notice before the next billing date
  • Compounded semaglutide and tirzepatide are not FDA-approved products

The bottom line

Best for: Shoppers who want one all-in price with no membership fee and are comfortable budgeting for a four-week billing cycle. Vyvron charges $199 every four weeks for compounded GLP-1 care at its founding-member rate, which adds up to 13 charges a year and rises to $249 once its founding spots fill.

For comparison, read our review of CoreAge Rx, one of our partners. Partners are listed first on our leaderboard; every provider is scored on the same six factors.

Other programs to compare with Vyvron

These are partners: we may earn a commission if you sign up, at no cost to you.

  • HealthRXPartner

    Semaglutide from $190/mo · tirzepatide from $239/mo

    HealthRX charges $190 a month for compounded semaglutide and $239 for tirzepatide month to month; the $99 and $179 it advertises are prepaid twelve-month prices.

  • SkinnyRxPartner

    Semaglutide from $249/mo · tirzepatide from $299/mo

    SkinnyRx charges $99 for the first month of compounded semaglutide or tirzepatide, then $249 or $299 a month; prepaid plans bring semaglutide down to $199 a month.

  • Bodybuilding Health+Partner

    Semaglutide from $179/mo · tirzepatide from $209/mo

    The Bodybuilding.com brand's telehealth arm charges $179 a month for compounded semaglutide and $209 for tirzepatide, with discounts for three, six and twelve months.

Compare with other providers

The providers whose Cost-Efficiency Index scores sit closest to Vyvron's. See the alternatives to Vyvron.

The 22 programs nearest this one

Pricing, states and verification reflect Vyvron's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on Vyvron's site. Not medical advice; see our disclosure.

← Back to the value leaderboard